# Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post‐revumenib therapies

**Authors:** Miles Thomas, Hannah Johnston, Emily Dworkin, Austin Wesevich, Gregory W. Roloff, Caner Saygin, Mariam T. Nawas, Michael W. Drazer, Adam S. DuVall, Satyajit Kosuri, Michael J. Thirman, Olatoyosi Odenike, Wendy Stock, Richard A. Larson, Rafael Madero‐Marroquin, Anand A. Patel

PMC · DOI: 10.1111/bjh.70225 · British Journal of Haematology · 2025-10-26

## Full-text entities

- **Diseases:** acute leukaemia (MESH:D054218)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12819088/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12819088/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12819088/full.md

---
Source: https://tomesphere.com/paper/PMC12819088